It’s a pleasure working with [the PHAR team]. I’m always confident they will deliver scientifically rigorous and clinically meaningful research that meets our study objectives.

Zhixiao Jason Wang, PhD, Senior Director, Health Economics & Outcomes Research, Eisai, Inc.
2017-06-19T18:37:13+00:00
It’s a pleasure working with [the PHAR team]. I’m always confident they will deliver scientifically rigorous and clinically meaningful research that meets our study objectives. Zhixiao Jason Wang, PhD, Senior Director, Health Economics & Outcomes Research, Eisai, Inc.
[The team is] a pleasure to work with on HEOR projects. [They bring] great insights along with a very practical viewpoint on how to get things done.

Lisa Rosenblatt Associate Director, Bristol-Myers Squibb
2015-01-06T21:37:35+00:00
[The team is] a pleasure to work with on HEOR projects. [They bring] great insights along with a very practical viewpoint on how to get things done. Lisa Rosenblatt Associate Director, Bristol-Myers Squibb
Michael and his team offer invaluable clinical and research consulting services. In addition to the expertise and excellent work provided, he is also a pleasure to work with. I can not recommend them more!

Russell Knoth Director, Health Economics and Outcomes at Eisai Pharmaceuticals
2014-10-21T23:51:48+00:00
Michael and his team offer invaluable clinical and research consulting services. In addition to the expertise and excellent work provided, he is also a pleasure to work with. I can not recommend them more! Russell Knoth Director, Health Economics and Outcomes at Eisai Pharmaceuticals
I've worked with Michael Broder and his team at PHAR on numerous projects over many years — they consistently deliver high quality analyses and reports, on budget and on time. They have tremendous expertise in many different therapeutic areas. I give them my highest recommendation!

Paul Solari Medical Affairs, Genentech
2014-10-21T23:52:50+00:00
I’ve worked with Michael Broder and his team at PHAR on numerous projects over many years — they consistently deliver high quality analyses and reports, on budget and on time. They have tremendous expertise in many different therapeutic areas. I give them my highest recommendation! Paul Solari Medical Affairs, Genentech
Michael is a superb health services researcher who emphasizes the importance of clinically-informed economic modeling and outcomes research. Michael is personable, flexible, and has a brilliant team that is responsive to our needs.

Edward Kim, MD, MBA Clinical Leader, Psychiatry Medical Affairs at Janssen, Pharmaceutical Companies of Johnson and Johnson
2014-10-21T23:49:46+00:00
Michael is a superb health services researcher who emphasizes the importance of clinically-informed economic modeling and outcomes research. Michael is personable, flexible, and has a brilliant team that is responsive to our needs. Edward Kim, MD, MBA Clinical Leader, Psychiatry Medical Affairs at Janssen, Pharmaceutical Companies of Johnson and Johnson
[PHAR is] professional in every sense of the word and has a great ability to understand our need, relate it to our company strategic objective and form-fit a HEOR vision to each project. Additionally Tanya guides her team towards the successful completion of these strategic goals through fulfillment of a wonderful work product.

Scott Megaffin Senior Vice President, Onconova Therapeutics, Inc.
2015-01-06T21:38:24+00:00
[PHAR is] professional in every sense of the word and has a great ability to understand our need, relate it to our company strategic objective and form-fit a HEOR vision to each project. Additionally Tanya guides her team towards the successful completion of these strategic goals through fulfillment of a wonderful work product. Scott Megaffin Senior Vice... read more
[PHAR is] a great business partner and can think of innovative solutions to complex [questions, bringing along] insight to the research questions in addition to creativity and experience to determine the best solutions. [The] project teams have always delivered timely, accurate and meaningful results to support our products value propositions.

Mitra Corral Strategic Health Economics and Market Access Professional experienced in developing Lifecycle Evidence of Value
2015-01-06T21:36:38+00:00
[PHAR is] a great business partner and can think of innovative solutions to complex [questions, bringing along] insight to the research questions in addition to creativity and experience to determine the best solutions. [The] project teams have always delivered timely, accurate and meaningful results to support our products value propositions. Mitra Corral Strategic Health Economics and Market... read more
I can always rely on your team when I need high quality work and a creative partner to work with. [Your] hard work and flexibility…allowed us to deliver high-quality products with shortened timelines and expanded scopes of work.

Evgeniya Antonova, PhD, Senior Health Economist, Genentech
2017-04-13T20:55:12+00:00
I can always rely on your team when I need high quality work and a creative partner to work with. [Your] hard work and flexibility…allowed us to deliver high-quality products with shortened timelines and expanded scopes of work. Evgeniya Antonova, PhD, Senior Health Economist, Genentech
Michael combines rigorous methodology with clinical expertise to deliver high quality health services research that is both practical and relevant. His team delivers projects on time, but are willing to be flexible if needed to ensure that the study objectives are met.

Ben Gutierrez TA Lead, Global Value Evidence & Outcomes, GlaxoSmithKline
2014-10-21T23:52:18+00:00
Michael combines rigorous methodology with clinical expertise to deliver high quality health services research that is both practical and relevant. His team delivers projects on time, but are willing to be flexible if needed to ensure that the study objectives are met. Ben Gutierrez TA Lead, Global Value Evidence & Outcomes, GlaxoSmithKline

CLIENTS

PHAR works with many of the largest pharmaceutical, biotechnology, and medical device companies in the United States, including:

AbbVie
Amgen
AstraZeneca
Bard
BMS
Boston Scientific
Celgene
Cholangiocarcinoma Foundation
Eli Lilly
Eisai
Ethicon
Genentech
Genomic Health
Helsinn
Ionis

Ipsen
Janssen
Jazz
Johnson & Johnson
Kite
Novartis
Otsuka
Pathnostics
Prothena

Roche
Sage

ACADEMIC PARTNERS

PHAR has ongoing collaborations with academic centers and research organizations around the country, including:

ASCO

American Society of Clinical Oncology

ASTRO

American Society for Radiation Oncology

Harbor-UCLA Medical Center

Division of Endocrinology

Harvard

The Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Massachusetts General Hospital

Mount Sinai

Icahn School of Medicine

NIH

The National Institute of Child Health & Human Development, National Institutes of Health (NIH)

Stanford

Stanford University School of Medicine

UCLA

The Center for Surgical Outcomes and Quality, David Geffen School of Medicine at UCLA

University of Miami

Jackson Health System, Miller School of Medicine

University of Rochester Medical Center

School of Medicine and Dentistry

USC

Keck Medical Center